SOXL vs XBI
Direxion Daily Semiconductor Bull 3X ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.75% for SOXL.
- • XBI pays a higher dividend yield (0.36%).
Side-by-side metrics
| Metric | SOXL | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.00% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $31.60B | $10.73B |
YTD return | 315.94% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 7.64 | 1.10 |
P/E ratio | 33.97 | — |
Last price | $199.85 | $164.01 |
Inception | — | — |
Issuer | Direxion | State Street |
SOXL top holdings
| MU | Micron Technology Inc | 5.50% |
| AMD | Advanced Micro Devices Inc | 5.21% |
| NVDA | NVIDIA Corp | 4.38% |
| INTC | Intel Corp | 4.07% |
| AVGO | Broadcom Inc | 3.91% |
| AMAT | Applied Materials Inc | 3.72% |
| KLAC | KLA Corp | 3.63% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About SOXL
SOXL (Direxion Daily Semiconductor Bull 3X ETF) is 3x daily performance of semiconductor stocks. Managed by Direxion, the fund carries $31.6B in assets under management, an expense ratio of 0.75%. Its largest holding is Micron Technology Inc (MU), which represents 5.5% of the portfolio. Technology is the fund's largest sector exposure at 100.0%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.